Results 181 to 190 of about 1,650,847 (244)

Loss‐of‐Function Variants in CCDC189 Cause Human Oligoasthenoteratozoospermia by Disrupting Sperm Flagellar and Acrosomal Architecture

open access: yesAndrology, EarlyView.
ABSTRACT Background Oligoasthenoteratozoospermia (OAT), characterized by reduced sperm count, impaired motility, and abnormal morphology, is a major cause of male infertility with substantial genetic heterogeneity. However, the underlying genetic etiology remains unresolved in a large proportion of affected individuals.
Jianteng Zhou   +8 more
wiley   +1 more source

Multiple polygenic score approach in colorectal cancer risk prediction. [PDF]

open access: yesSci Rep
Jiang SJ   +43 more
europepmc   +1 more source

Macular telangiectasia type 2 genetic risk variants associated with clinical characteristics in the Slovenian cohort

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Early diagnosis of macular telangiectasia type 2 (MacTel) remains challenging, and the contribution of genetic variation to its clinical heterogeneity is unclear. This study investigated associations between MacTel risk variants and clinical characteristics in a Slovenian cohort.
Ajda Kunčič   +4 more
wiley   +1 more source

Correction: Validation of a genome-wide polygenic score for body mass index in South Asians. [PDF]

open access: yesFront Genet
Menon R   +13 more
europepmc   +1 more source

Early Life Neurodevelopmental Indicators of Attention‐Deficit/Hyperactivity Disorder at Age 10: A Prospective Cohort Study

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Attention‐deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder associated with long‐term adverse outcomes, yet diagnosis often occurs years after symptoms first emerge. Because ADHD involves impairments across multiple developmental domains, early deviations in language, cognition, motor development and ...
Camilla Grube   +12 more
wiley   +1 more source

Review Article: Fibrosis‐4 Index in Steatotic Liver Disease—Past, Present and Future

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
FIB‐4 remains an inexpensive, scalable first‐line triage tool for excluding advanced fibrosis and identifying patients who need second‐line assessment, but it should not be used as a stand‐alone diagnostic or treatment‐selection test. Sequential testing and longitudinal FIB‐4 trajectories may improve risk stratification and prognosis.
Kriti Soni   +6 more
wiley   +1 more source

Evaluating a Genome-Wide Polygenic Score for Handgrip Strength and Its Interplay with Leisure-Time Physical Activity Across the IGEMS Twin Cohorts. [PDF]

open access: yesMed Sci Sports Exerc
Herranen P   +13 more
europepmc   +1 more source

The PSA test for prostate cancer screening: an abridged Cochrane review

open access: yesBJU International, EarlyView.
Objectives To assess the effects of prostate cancer screening compared to no screening in men with no prior diagnosis of prostate cancer. Methods This systematic review represents an update of a prior Cochrane review from 2013, searching multiple databases up to November 2025. We included randomised controlled trials (RCTs) of prostate cancer screening
Juan V. A. Franco   +6 more
wiley   +1 more source

Effects of lifelong sulforaphane intake on behavioural, neurochemical and biomolecular dysfunctions in the BTBR T+ Itpr3tf/J mouse model of autism spectrum disorders

open access: yesBritish Journal of Pharmacology, EarlyView.
Created in BioRender. Schiavone, S. (2026). https://BioRender.com/cy0xq6z. Abstract Background and Purpose Autism spectrum disorders (ASD) are multifactorial neurodevelopmental conditions associated with oxidative stress and neuroinflammation across critical developmental periods.
Vladyslav Sikora   +8 more
wiley   +1 more source

Body mass index threshold for obesity should be personalized based on polygenic score: Analysis of european and east asian biobanks. [PDF]

open access: yesAm J Prev Cardiol
Kim MS   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy